SCHEMBL1630477

SCHEMBL1630477

COc1cc(OC)c(-c2ccnn2-c2ccccc2Cl)cc1NCc1ccccn1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HSP90AA1 P07900 1/20 0.51
KMT2A Q03164 7/20 0.48
MEN1 O00255 5/20 0.48
GAA P10253 3/20 0.48
ALDH1A1 P00352 3/20 0.48
HPGD P15428 3/20 0.48
KDM4E B2RXH2 2/20 0.48
ALOX15 P16050 2/20 0.48
HSD17B10 Q99714 2/20 0.48
MAPT P10636 1/20 0.48
RAB9A P51151 1/20 0.48
L3MBTL1 Q9Y468 4/20 0.41
PKM P14618 1/20 0.41
SMN1; SMN2 Q16637 2/20 0.40
TP53 P04637 1/20 0.40
PGK1 P00558 1/20 0.40
LMNA P02545 1/20 0.39
HTT P42858 1/20 0.39
USP2 O75604 1/20 0.38
CYP1A2 P05177 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1629172 0.84 HSP90AA1 (0.41) HSP90AA1KMT2AMEN1GAAALDH1A1
SCHEMBL1628585 0.83 HSP90AA1 (0.69) HSP90AA1KMT2AMEN1ALDH1A1HPGD
SCHEMBL1629208 0.80 P2RX7 (0.43) HSP90AA1KMT2AMEN1MAPT
SCHEMBL1629896 0.76 KCNN4 (0.44) HSP90AA1MAPT
SCHEMBL1629564 0.76 HSP90AA1 (0.44) HSP90AA1ALDH1A1MAPTMAPK1
SCHEMBL1630462 0.75 HSP90AA1 (0.44) HSP90AA1GAAKDM4EMAPTRAB9A
SCHEMBL1630458 0.75 HSP90AA1 (0.44) HSP90AA1GAAKDM4EMAPTRAB9A
SCHEMBL1630429 0.75 PTGER1 (0.46) HSP90AA1ALDH1A1HPGDKDM4EHSD17B10
SCHEMBL12722876 0.74 HSP90AA1 (0.46) HSP90AA1MAPT
SCHEMBL1630297 0.73 HSP90AA1 (0.41) HSP90AA1GAAALDH1A1HPGDKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1776346-B1 1,5-Diphenylpyrazoles MERCK PATENT GMBH (DE) 2013-06-26 EP disclosed
US-7932401-B2 Heat Shock Protein 90 (HSP90) inhibitors; 5-(2-hydroxy-4-methoxyphenyl)-1-(3-nitrophenyl)-1H-pyrazole for example; antitumor agent, viral diseases, transplant rejection, cystic fibrosis, angiogenesis inhibition, infectious, autoimmune, or inflammatory diseases, ischemia, chemotherapy cytoprotectant MERCK PATENT GMBH (DE) 2011-04-26 US disclosed
US-20080085904-A1 1,5-Diphenylpyrazoles MERCK PATENT GMBH (DE) 2008-04-10 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080085904-A1 1,5-Diphenylpyrazoles HSP90AB1, HSP90AA1, HSP90AB2P HSP90AA1 2/4885KMT2A 4362/4885MEN1 4538/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.